Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed No phase listed Observational

Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification

ClinicalTrials.gov ID: NCT01839045

Public ClinicalTrials.gov record NCT01839045. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 4, 2026, 5:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Breast Cancer Biomarker Sample Collection for the DtectDx Assay Proof of Concept

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The major purpose of this study is to evaluate a laboratory developed test that measures multiple breast cancer-specific biomarker proteins in your blood samples. The biomarker results along with your personal medical profile will be evaluated to determine your risk for the presence of a malignancy in the breast as compared to your breast evaluation assessment conducted by your physician.

Study identification

NCT ID
NCT01839045
Recruitment status
Not listed
Study type
Observational
Phase
Not listed
Lead sponsor
Provista Diagnostics, Inc
Industry
Enrollment
350 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range
25 Years to 49 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2013 (Type not available)
Primary completion
Jun 2014 (Actual)
Completion
Aug 2014 (Estimated)
Last update posted
Jun 9, 2014

2013 – 2014

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
Banner Health Phoenix Arizona 85006 —
Sutter Institute Sacramento California 95816 —
Scripps San Diego California 92103 —
Sansum Clinic Santa Barbara California 93102-1200 —
Lahey Clinic Peabody Massachusetts 01960 —
Henry Ford Hospital Detroit Michigan 48202 —
Rhode Island Hospital Providence Rhode Island 02903 —
Avera Research Institute Sioux Falls South Dakota 57105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01839045, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 9, 2014 · Synced Oct 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01839045 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →